Meeting highlights for Society of Nuclear Medicine

June 05, 2002

HIGHLIGHTS:

Terrorism Involving Radioactive Materials
Saturday, June 15, 2002
12:00-4:30 pm Room 409 AB
PRESS CREDENTIALS REQUIRED. PREREGISTRATION PREFERRED.
What should health care professionals plan for? What are some of the radiation-related misconceptions that could affect care? Includes possible types of terrorist attacks and practical problems when implementing citywide response plans, preparing hospitals for terrorist events involving radioactive material, and the types and management of radiation injuries.

PRESS BRIEFINGS

SNM Leadership Brief the Media
Sunday, 06/16/02 11:00 a.m. Room 303A
SNM leadership and leadership of the SNM Technologist Section (SNMTS)
  • An overview of the Nuclear Medicine profession,
  • What shortages of technologists and others can mean for patient care, and how to solve them;
  • PET initiatives and reimbursement issues.
  • Introduction of SNM's new logo and tag line.

    Medical Breakthroughs, Image of the Year
    Monday 06/17/02: Room 303A 11:30 a.m.
  • Radioimmunotherapy is the next generation of cancer fighting drugs. In 2002 it "arrived."
  • PET: predicting if chemotherapy will succeed.
  • SPECT shows diabetics without symptoms at risk.
  • PET Finds ¼ of cardiology patients on lipid-lowering drugs may still be at risk for CAD
  • Dr. Henry Wagner introduces "Images of the Year." (Images available at the briefing.)
  • PET/CT.

    Society of Nuclear Medicine

    Related Chemotherapy Articles from Brightsurf:

    Chemotherapy is used to treat less than 25% of people with localized sarcoma
    UCLA researchers have found that chemotherapy is not commonly used when treating adults with localized sarcoma, a rare type of cancer of the soft tissues or bone.

    Starved cancer cells became more sensitive to chemotherapy
    By preventing sugar uptake, researchers succeeded in increasing the cancer cells' sensitivity to chemotherapeutic treatment.

    Vitamin D could help mitigate chemotherapy side effects
    New findings by University of South Australia researchers reveal that Vitamin D could potentially mitigate chemotherapy-induced gastrointestinal mucositis and provide relief to cancer patients.

    Less chemotherapy may have more benefit in rectal cancer
    GI Cancers Symposium: Colorado study of 48 patients with locally advanced rectal cancer receiving neoadjuvant chemotherapy, found that patients receiving lower-than-recommended doses in fact saw their tumors shrink more than patients receiving the full dose.

    Male fertility after chemotherapy: New questions raised
    Professor Delb├Ęs, who specializes in reproductive toxicology, conducted a pilot study in collaboration with oncologists and fertility specialists from the McGill University Health Centre (MUHC) on a cohort of 13 patients, all survivors of pediatric leukemia and lymphoma.

    'Combo' nanoplatforms for chemotherapy
    In a paper to be published in the forthcoming issue in NANO, researchers from Harbin Institute of Technology, China have systematically discussed the recent progresses, current challenges and future perspectives of smart graphene-based nanoplatforms for synergistic tumor therapy and bio-imaging.

    Nanotechnology improves chemotherapy delivery
    Michigan State University scientists have invented a new way to monitor chemotherapy concentrations, which is more effective in keeping patients' treatments within the crucial therapeutic window.

    Novel anti-cancer nanomedicine for efficient chemotherapy
    Researchers have developed a new anti-cancer nanomedicine for targeted cancer chemotherapy.

    Ending needless chemotherapy for breast cancer
    A diagnostic test developed at The University of Queensland might soon determine if a breast cancer patient requires chemotherapy or would receive no benefit from this gruelling treatment.

    A homing beacon for chemotherapy drugs
    Killing tumor cells while sparing their normal counterparts is a central challenge of cancer chemotherapy.

    Read More: Chemotherapy News and Chemotherapy Current Events
  • Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.